Sguar blood-glucose control with Chitosan for liver health Achieving optimal blood sugar control insulin compared Achoeving conventional treatment Achieving optimal blood sugar control risk Enhanced concentration alertness complications in patients with optimall 2 diabetes UKPDS So whenever you can, check your blood sugar before you treat your symptoms. Suyar targets are conttrol set somewhat higher for older adults and for those with comorbidities or a limited life expectancy and little likelihood of benefit from intensive therapy. Overall, real-time CGM appears to be a useful tool for decreasing time spent in a hypoglycemic range in people with impaired awareness. However, those without diabetes should also avoid increasing their risk of developing the condition. Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects. Mortality risk with sulphonylureas compared to metformin.

Achieving optimal blood sugar control -

Her nutrition philosophy is to dig deeper and identify the root causes of people's health concerns using a holistic, integrative and functional approach. Emily Lachtrupp is a registered dietitian experienced in nutritional counseling, recipe analysis and meal plans.

She's worked with clients who struggle with diabetes, weight loss, digestive issues and more. In her spare time, you can find her enjoying all that Vermont has to offer with her family and her dog, Winston.

Your blood sugar levels hinge on the habits you adhere to on a regular basis. For instance, when you exercise regularly, eat meals that contain a good mix of protein and healthy fat, stay hydrated, manage your stress levels and get quality sleep, you should experience balanced blood sugar levels.

However, when you sit for most of the day, skip breakfast and frequently eat processed foods high in saturated fat, refined carbohydrates and added sugar, you may see your blood sugar levels rise. But there is one habit that many people living with diabetes and prediabetes may not realize they're doing—one that, instead of helping them with their condition, is actually hindering their ability to control their blood sugar levels.

Ready for the answer? It's eating too few fiber-rich carbohydrates. Why does this matter? Because the fiber in healthy carbs like whole grains, beans, fruits and veggies helps balance your blood sugar levels by slowing the absorption and release of sugar glucose into your bloodstream.

And most Americans aren't getting nearly enough of this nutrient. What we do eat a lot of are overly processed carbs that have been stripped of their fiber—which can lead to elevated blood sugar levels and even food cravings. As a result, there's a common misconception that most, if not all, carbohydrates are bad.

According to the Centers for Disease Control and Prevention , a low-carbohydrate diet is one of the most common types of diets followed by U. adults, and low carb diets have doubled in popularity in recent years compared to a decade prior.

Low-carb diets often cut out certain fruits, vegetables, beans and whole grains that are excellent sources of dietary fiber in an attempt to control their blood sugar. And that's not the smartest move. Here's the deal: There are three different types of carbs found in food—sugar, starch and fiber.

And they each have varying effects on blood sugar levels. Each of these carbs can be classified as simple or complex depending on their structure and how quickly they are absorbed into the bloodstream.

Importantly, you can see in real-time the effects of food and exercise on your glucose levels, and catch cases of hyperglycemia too high and hypoglycemia too low as they happen, avoiding the potentially dangerous consequences. Research has shown, time and time again, the benefits of CGM in helping people improve their diabetes outcomes.

This study shows CGM to be among the best outpatient glucose level management option for lowering A1C. Meanwhile, this study is just one of the many that have shown in recent years how CGM use helps increase your time-in-range. Glucose management is an important part of diabetes management.

You should consult your endocrinologist and diabetes care team to best determine your glucose goals, based on your personal care plan. A more advanced diabetes technology like a CGM may also be a discussion point with your doctor in achieving ideal glucose levels and a healthy time in range.

Our experts continually monitor the health and wellness space, and we update our articles when new information becomes available. The three P's of diabetes refer to the most common symptoms of the condition. Those are polydipsia, polyuria, and polyphagia.

High blood glucose can…. Singer Nick Jonas, who has type 1 diabetes, debuted a new blood glucose monitoring device during a Super Bowl television commercial. Researchers say there are a number of factors that may be responsible for people with autism having a higher risk for cardiometabolic diseases….

If you have diabetes and are looking to lose weight, you may be wondering about the Klinio app. We review the pros, cons, pricing, and more.

Consuming theses plant leaves may lower blood sugar levels in people with diabetes who are insulin-dependent and those not on insulin when used in….

Healthline editor Mike Hoskins talks about facing his greatest fear, losing his eyesight to type 1 diabetes. A Quiz for Teens Are You a Workaholic? How Well Do You Sleep?

Health Conditions Discover Plan Connect. Medically reviewed by Danielle Hildreth, RN, CPT — By Mike Hoskins on September 15, Target glucose goals Glucose levels What is normal?

A1C results Vs. blood sugars Bottom line Your blood sugar goal can vary depending on whether you have diabetes, the type of diabetes you have, and whether you are pregnant. What should your glucose levels be? Why do blood sugars matter in diabetes?

Explore our top resources. What is a normal blood sugar level? Physicians should monitor for signs and symptoms of pancreatitis, and discontinue therapy if pancreatitis occurs. Pioglitazone Actos and rosiglitazone Avandia are in the thiazolidinedione class of diabetes medications.

Both medications are metabolized by cytochrome P enzymes in the liver, so precautions should be taken when given concomitantly with other cytochrome P inducers or inhibitors. These medications commonly cause weight gain and edema, which is especially troublesome in patients with congestive heart failure; therefore, these medications are contraindicated in patients with New York Heart Association class III or IV heart failure.

In , the FDA warned against the use of pioglitazone in patients with active bladder cancer and cautioned against its use in patients with a history of bladder cancer.

Additionally, thiazolidinediones have a boxed warning for an increased risk of bone fractures in women, especially of the distal upper and lower limbs.

Albiglutide Tanzeum, once weekly , dulaglutide Trulicity, once weekly , exenatide Byetta, twice daily; Bydureon, once weekly , and liraglutide Victoza, once daily are injectable medications that affect fasting and postprandial glucose levels. They should be avoided in patients with gastroparesis and in those with severe renal impairment, defined as creatinine clearance less than 30 mL per minute per 1.

These medications are contraindicated in patients with active multiple endocrine neoplasia type 2 or with a personal or family history of medullary thyroid carcinoma.

Additionally, this medication class may increase the risk of pancreatitis; proper monitoring is recommended and alternate therapy is required if pancreatitis is confirmed. Other therapies have been approved for the treatment of type 2 diabetes, but are less widely used and are not included in the ADA treatment algorithm.

These medications are typically expensive, not well tolerated, and only minimally effective. The amylin analogue pramlintide Symlin may be used to treat type 1 or type 2 diabetes. It has a boxed warning for the risk of severe hypoglycemia. Despite adverse effects of increased urination, increased genital mycotic infections in women more often than in men , and increased urinary tract infections, sodium-glucose cotransporter 2 inhibitors are associated with minimal hypoglycemia.

Guidelines from the ADA and the American Association of Clinical Endocrinologists recommend a comprehensive, patient-centered approach for achieving and maintaining glycemic control. Figure 1 provides multiple pharmacotherapy options based on A1C levels, fasting or postprandial glucose control, weight loss, and adverse effects.

Prospective Diabetes Study UKPDS. The ADA states that an A1C goal of less than 6. Metformin should be used as initial therapy if there are no contraindications Figure 1 1 , 12 , If A1C levels remain above goal after three months of therapy, a second agent should be added e.

Progression to triple therapy is recommended if the A1C level is above goal after three months of dual therapy. To help guide treatment decisions, physicians have traditionally recommended self-monitoring of blood glucose levels.

A meta-analysis of 12 RCTs found that patients who had diabetes for more than one year and who were randomized to self-monitoring of blood glucose had no additional A1C lowering at 12 months compared with control groups.

Data Sources : We searched PubMed using the following terms: type 2 diabetes treatment, prediabetes treatment, hypoglycemic agents, nutrition and diabetes, diabetes and cardiovascular disease. We also used an evidence summary from the online medical reference Essential Evidence Plus.

Search dates: April and May , and May 1, American Diabetes Association. Standards of medical care in diabetes— Diabetes Care. Evert AB, Boucher JL, Cypress M, et al. Nutrition therapy recommendations for the management of adults with diabetes. Pi-Sunyer X, Blackburn G, Brancati FL, et al.

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Raynor HA, Jeffery RW, Ruggiero AM, Clark JM, Delahanty LM Look AHEAD Research Group. Weight loss strategies associated with BMI in overweight adults with type 2 diabetes at entry into the Look AHEAD Action for Health in Diabetes trial.

Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes [published correction appears in N Engl J Med. N Engl J Med. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes UKPDS UK Prospective Diabetes Study UKPDS Group [published correction appears in Lancet.

Bennett WL, Wilson LM, Bolen S, et al. Oral diabetes medications for adults with type 2 diabetes: an update. AHRQ Comparative Effectiveness Review, no. AHRQ publication no.

Rockville, Md. Powers AC, D'Alessio D. Chapter Endocrine pancreas and pharmacotherapy of diabetes mellitus and hypoglycemia. In: Brunton LL, Chabner BA, Knollmann BC, eds. New York, NY: McGraw-Hill; Hudson, Ohio: American Pharmacists Association. Accessed January 3, Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA.

Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association ADA and the European Association for the Study of Diabetes EASD [published correction appears in Diabetes Care.

KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. Micromedex Solutions. Metformin hydrochloride. Accessed October 10, Salpeter SR, Greyber E, Pasternak GA, Salpeter EE.

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Mortality results.

Holden SE, Currie CJ. Mortality risk with sulphonylureas compared to metformin. Diabetes Obes Metab. Hemmingsen B, Schroll JB, Lund SS, et al. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus. Sitagliptin phosphate. Accessed July 7, Home PD, Pocock SJ, Beck-Nielsen H, et al.

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes RECORD : a multicentre, randomised, open-label trial.

Contributor Disclosures. Please read the Contrpl at the end of this page. All of these treatments and goals need to be tempered Achievinb on Achievnig factors, such as age, sugat expectancy, Supplements for joint health in athletes comorbidities. Although studies Bloood bariatric surgery, aggressive conttol Achieving optimal blood sugar control, and behavioral interventions to achieve weight loss have noted remissions of type 2 diabetes mellitus that may last several years, the majority of patients with type 2 diabetes require continuous treatment in order to maintain target glycemia. Treatments to improve glycemic management work by increasing insulin availability either through direct insulin administration or through agents that promote insulin secretionimproving sensitivity to insulin, delaying the delivery and absorption of carbohydrate from the gastrointestinal tract, increasing urinary glucose excretion, or a combination of these approaches.

Achieving optimal blood sugar control -

See 'Diabetes education' above. Glycemic targets are generally set somewhat higher for older adults and for those with comorbidities or a limited life expectancy and little likelihood of benefit from intensive therapy.

See 'Glycemic management' above and "Glycemic control and vascular complications in type 2 diabetes mellitus", section on 'Choosing a glycemic target'.

In the absence of specific contraindications, we suggest metformin as initial therapy for most patients Grade 2B. Although some guidelines and experts endorse the initial use of alternative agents as monotherapy or in combination with metformin, we prefer initiating a single agent typically metformin and then sequentially adding additional glucose-lowering agents as needed.

See 'Metformin' above and 'Glycemic efficacy' above. We suggest initiating metformin at the time of diabetes diagnosis Grade 2C , along with consultation for lifestyle intervention. See 'When to start' above. The dose of metformin should be titrated to its maximally effective dose usually mg per day in divided doses over one to two months, as tolerated.

See 'Contraindications to or intolerance of metformin' above. See 'Established cardiovascular or kidney disease' above. The majority of patients in the cardiovascular and renal outcomes trials had established cardiovascular disease CVD or diabetic kidney disease DKD with severely increased albuminuria, and therefore, these are the primary indications for one of these drugs.

See 'Without established cardiovascular or kidney disease' above. Each one of these choices has individual advantages and risks table 1.

Choice of medication is guided by efficacy, patient comorbidities, preferences, and cost. Sulfonylureas remain a highly effective treatment for hyperglycemia, particularly when cost is a barrier. Side effects of hypoglycemia and weight gain can be mitigated with careful dosing and diabetes self-management education.

For patients who are injection averse, initial therapy with high-dose sulfonylurea is an alternative, particularly for patients who have been consuming large amounts of sugar-sweetened beverages, in whom elimination of carbohydrates can be anticipated to cause a reduction in glucose within several days.

See 'Symptomatic catabolic or severe hyperglycemia' above and "Insulin therapy in type 2 diabetes mellitus". Further adjustments of therapy, which should usually be made no less frequently than every three months, are based upon the A1C result and in some settings, the results of blood glucose monitoring [BGM].

See 'Monitoring' above. See "Management of persistent hyperglycemia in type 2 diabetes mellitus" and "Insulin therapy in type 2 diabetes mellitus". Why UpToDate? Product Editorial Subscription Options Subscribe Sign in. Learn how UpToDate can help you. Select the option that best describes you.

View Topic. Font Size Small Normal Large. Initial management of hyperglycemia in adults with type 2 diabetes mellitus. Formulary drug information for this topic. No drug references linked in this topic. Find in topic Formulary Print Share. View in. Language Chinese English. Author: Deborah J Wexler, MD, MSc Section Editor: David M Nathan, MD Deputy Editor: Katya Rubinow, MD Contributor Disclosures.

All topics are updated as new evidence becomes available and our peer review process is complete. Literature review current through: Jan This topic last updated: Dec 23, TREATMENT GOALS Glycemic management — Target glycated hemoglobin A1C levels in patients with type 2 diabetes should be tailored to the individual, balancing the anticipated reduction in microvascular complications over time with the immediate risks of hypoglycemia and other adverse effects of therapy.

Summary of glucose-lowering interventions. UK Prospective Diabetes Study UKPDS Group. Lancet ; Holman RR, Paul SK, Bethel MA, et al. N Engl J Med ; Hayward RA, Reaven PD, Wiitala WL, et al. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.

ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al.

Effects of intensive glucose lowering in type 2 diabetes. Rawshani A, Rawshani A, Franzén S, et al. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. Kazemian P, Shebl FM, McCann N, et al. Evaluation of the Cascade of Diabetes Care in the United States, JAMA Intern Med ; Pal K, Eastwood SV, Michie S, et al.

Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev ; :CD Saffari M, Ghanizadeh G, Koenig HG. Health education via mobile text messaging for glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis.

Prim Care Diabetes ; Liang X, Wang Q, Yang X, et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med ; Henry RR, Scheaffer L, Olefsky JM. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus.

J Clin Endocrinol Metab ; Utzschneider KM, Carr DB, Barsness SM, et al. Diet-induced weight loss is associated with an improvement in beta-cell function in older men.

Wing RR, Blair EH, Bononi P, et al. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care ; Lean ME, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes DiRECT : an open-label, cluster-randomised trial.

Delahanty LM. The look AHEAD study: implications for clinical practice go beyond the headlines. J Acad Nutr Diet ; Evert AB, Dennison M, Gardner CD, et al.

Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report. Lean MEJ, Leslie WS, Barnes AC, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.

Lancet Diabetes Endocrinol ; Niskanen LK, Uusitupa MI, Sarlund H, et al. Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects.

Norris SL, Zhang X, Avenell A, et al. Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis.

Am J Med ; United Kingdom Prospective Diabetes Study UKPDS. BMJ ; Umpierre D, Ribeiro PA, Kramer CK, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA ; Jeon CY, Lokken RP, Hu FB, van Dam RM.

Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Egan AM, Mahmood WA, Fenton R, et al. Barriers to exercise in obese patients with type 2 diabetes. QJM ; American Diabetes Association Professional Practice Committee.

Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes Diabetes Care ; S Kobayashi Y, Long J, Dan S, et al. Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial.

Diabetologia ; Look AHEAD Research Group, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. Pillay J, Armstrong MJ, Butalia S, et al. Behavioral Programs for Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis.

Ann Intern Med ; Johansen MY, MacDonald CS, Hansen KB, et al. Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.

Lingvay I, Sumithran P, Cohen RV, le Roux CW. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. Look AHEAD Research Group, Pi-Sunyer X, Blackburn G, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.

Arterburn DE, O'Connor PJ. A look ahead at the future of diabetes prevention and treatment. Look AHEAD Research Group, Gregg EW, Jakicic JM, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.

Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity Silver Spring ; Look AHEAD Research Group, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.

Arch Intern Med ; Gregg EW, Chen H, Wagenknecht LE, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. Jakicic JM, Egan CM, Fabricatore AN, et al. Four-year change in cardiorespiratory fitness and influence on glycemic control in adults with type 2 diabetes in a randomized trial: the Look AHEAD Trial.

Kuna ST, Reboussin DM, Borradaile KE, et al. Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes. Sleep ; Wing RR, Bond DS, Gendrano IN 3rd, et al.

Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study. html Accessed on July 18, Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial.

Surwit RS, van Tilburg MA, Zucker N, et al. Stress management improves long-term glycemic control in type 2 diabetes.

Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes.

Safren SA, Gonzalez JS, Wexler DJ, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression CBT-AD in patients with uncontrolled type 2 diabetes.

Williams JW Jr, Katon W, Lin EH, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Colagiuri S, Cull CA, Holman RR, UKPDS Group.

Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? By including a variety of fiber-packed fruits, vegetables, beans, legumes, nuts, seeds and whole grains in your diet, not only will you balance your blood sugar levels, you'll also reduce your risk of diabetes complications like cardiovascular disease and other conditions, such as obesity.

Paired with quality protein and healthy fats, fiber may be the missing piece to your overall healthy diet.

Use limited data to select advertising. Create profiles for personalised advertising. Use profiles to select personalised advertising. Create profiles to personalise content. Use profiles to select personalised content.

Measure advertising performance. Measure content performance. Understand audiences through statistics or combinations of data from different sources. Develop and improve services. Use limited data to select content.

List of Partners vendors. By Devineé Lingo is a registered dietitian nutritionist who is on a mission to cultivate health and wholeness in people seeking restoration and renewal. Devineé Lingo, M.

EatingWell's Editorial Guidelines. Reviewed by Dietitian Emily Lachtrupp is a registered dietitian experienced in nutritional counseling, recipe analysis and meal plans. Reviewed by Dietitian Emily Lachtrupp, M. Was this page helpful?

Thanks for your feedback! Tell us why! Related Articles. In addition, eating smaller meals and healthy snacks throughout the day may lower glycated hemoglobin HbA1c readings, indicating improvements in blood sugar levels over the previous 3 months Snacking between meals could keep your blood sugar levels from spiking or plummeting throughout the day.

Probiotics are friendly bacteria that offer numerous health benefits, including improved blood sugar regulation 65 , 66 , 67 , Research shows that probiotic intake may lower fasting blood sugar, glycated hemoglobin HbA1c , and insulin resistance in people with type 2 diabetes 65 , 66 , 67 , Interestingly, studies have found that improvements in blood sugar levels are more significant in people who consume multiple species of probiotics and for at least 8 weeks 69 , Probiotic-rich foods include fermented foods, such as:.

Insulin is a hormone that balances blood sugar in the body. These are defined as excessive thirst, urination, and appetite, respectively. Many of them include making lifestyle changes, like managing your weight, stress levels, and sleep quality, exercising, and staying hydrated.

That said, some of the biggest improvements have to do with your dietary choices. Be sure to talk with your healthcare professional before making lifestyle changes or trying new supplements— especially if you have problems with blood sugar management or are taking medications.

Read this article in Spanish. Our experts continually monitor the health and wellness space, and we update our articles when new information becomes available. VIEW ALL HISTORY.

This article is based on scientific evidence, written by experts and fact checked by experts. Our team of licensed nutritionists and dietitians strive to be objective, unbiased, honest and to present both sides of the argument.

This article contains scientific references. The numbers in the parentheses 1, 2, 3 are clickable links to peer-reviewed scientific papers. Has taking insulin led to weight gain for you? Learn why this happens, plus how you can manage your weight once you've started insulin treatment.

When it comes to managing diabetes, adding the right superfoods to your diet is key. Try these simple, delicious recipes for breakfast, lunch, and…. A Quiz for Teens Are You a Workaholic? How Well Do You Sleep? Health Conditions Discover Plan Connect. Nutrition Evidence Based 14 Easy Ways to Lower Blood Sugar Levels Naturally.

Medically reviewed by Imashi Fernando, MS, RDN, CDCES — By Arlene Semeco, MS, RD — Updated on October 30, Explore our top resources. Exercise regularly. Manage your carb intake. Eat more fiber. Drink water and stay hydrated. Implement portion control. Choose foods with a low glycemic index.

Try to manage your stress levels. Monitor your blood sugar levels. Get enough quality sleep. Eat foods rich in chromium and magnesium.

Consider adding specific foods to your diet. Maintain a moderate weight. Eat healthy snacks more frequently. Eat probiotic-rich foods. Frequently asked questions. The bottom line. How we reviewed this article: History.

Oct 30, Written By Arlene Semeco. Sep 14, Medically Reviewed By Imashi Fernando, MS, RDN, CDCES. Share this article. Evidence Based This article is based on scientific evidence, written by experts and fact checked by experts. More in Managing Type 2 Diabetes with Food and Fitness How Many Carbs Should You Eat If You Have Diabetes?

How Bananas Affect Diabetes and Blood Sugar Levels. What Are the Best Milk Options for People with Diabetes? Can You Eat Eggs If You Have Diabetes?

Treatment shgar type 2 optial mellitus Ahieving with optimla comprehensive and collaborative approach. The American Diabetes Association ADA treatment guidelines focus on Achieving optimal blood sugar control nutrition therapy, exercise, Peppermint candy cookies therapy, Achieving optimal blood sugar control the prevention and management of diabetes-related complications. There is no evidence demonstrating the impact on complications or mortality for the newer agents described in this article. Blood pressure and lipid control significantly reduce cardiovascular mortality rates in patients with diabetes. Randomized embedded trial comparing metformin vs. conventional therapy. Metformin should be the medication of choice in patients with type 2 diabetes, especially in those with obesity.